In vitro gene expression-coupled bacterial cell chip for screening species-specific antimicrobial enzymes

Seok Joon Kwon, Domyoung Kim, Inseon Lee, Jungbae Kim, Jonathan S. Dordick

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Targeting infectious bacterial pathogens is important for reducing the evolution of antibiotic-resistant bacteria and preserving the endogenous human microbiome. Cell lytic enzymes including bacteriophage endolysins, bacterial autolysins, and other bacteriolysins are useful antibiotic alternatives due to their exceptional target selectivity, which may be used to lysins rapidly kill target bacteria and their high specificity permit the normal commensal microflora to be left undisturbed. Genetic information of numerous lysins is currently available, but the identification of their antimicrobial function and specificity has been limited because most lysins are often poorly expressed and exhibit low solubilities. Here, we report the development of bacterial cell chip for rapidly accessing the function of diverse genes that are suggestive of encoding lysins. This approach can be used to evaluate rapidly the species-specific antimicrobial activity of diverse lysins synthesized from in vitro transcription and translation (TNT) of plasmid DNA. In addition, new potent lysins can be assessed that are not expressed in hosts and display low solubility. As a result of evaluating the species-specific antimicrobial function of 11 (un)known lysins with an in vitro TNT-coupled bacterial cell chip, a potent recombinant lysin against Staphylococcus strains, SA1, was identified. The SA1 was highly potent against not only S. aureus, but also both lysostaphin-resistant S. simulans and S. epidermidis cells. To this end, the SA1 may be applicable to treat both methicillin-resistant S. aureus (MRSA) and lysostaphin-resistant MRSA mutants. Biotechnol. Bioeng. 2017;114: 1648–1657.

Original languageEnglish
Pages (from-to)1648-1657
Number of pages10
JournalBiotechnology and Bioengineering
Volume114
Issue number8
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

Lysostaphin
Gene expression
Screening
Methicillin
Enzymes
Antibiotics
Gene Expression
Methicillin Resistance
Bacteria
Solubility
N-Acetylmuramoyl-L-alanine Amidase
Anti-Bacterial Agents
Bacteriophages
Pathogens
Transcription
Microbiota
Plasmids
DNA
Genes
Staphylococcus

Keywords

  • bacterial cell chip
  • high-throughput screening
  • in vitro TNT
  • lysins
  • SA1

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

In vitro gene expression-coupled bacterial cell chip for screening species-specific antimicrobial enzymes. / Kwon, Seok Joon; Kim, Domyoung; Lee, Inseon; Kim, Jungbae; Dordick, Jonathan S.

In: Biotechnology and Bioengineering, Vol. 114, No. 8, 01.08.2017, p. 1648-1657.

Research output: Contribution to journalArticle

Kwon, Seok Joon ; Kim, Domyoung ; Lee, Inseon ; Kim, Jungbae ; Dordick, Jonathan S. / In vitro gene expression-coupled bacterial cell chip for screening species-specific antimicrobial enzymes. In: Biotechnology and Bioengineering. 2017 ; Vol. 114, No. 8. pp. 1648-1657.
@article{60afbf8fda1b48a4af9dbfe8fc3058ed,
title = "In vitro gene expression-coupled bacterial cell chip for screening species-specific antimicrobial enzymes",
abstract = "Targeting infectious bacterial pathogens is important for reducing the evolution of antibiotic-resistant bacteria and preserving the endogenous human microbiome. Cell lytic enzymes including bacteriophage endolysins, bacterial autolysins, and other bacteriolysins are useful antibiotic alternatives due to their exceptional target selectivity, which may be used to lysins rapidly kill target bacteria and their high specificity permit the normal commensal microflora to be left undisturbed. Genetic information of numerous lysins is currently available, but the identification of their antimicrobial function and specificity has been limited because most lysins are often poorly expressed and exhibit low solubilities. Here, we report the development of bacterial cell chip for rapidly accessing the function of diverse genes that are suggestive of encoding lysins. This approach can be used to evaluate rapidly the species-specific antimicrobial activity of diverse lysins synthesized from in vitro transcription and translation (TNT) of plasmid DNA. In addition, new potent lysins can be assessed that are not expressed in hosts and display low solubility. As a result of evaluating the species-specific antimicrobial function of 11 (un)known lysins with an in vitro TNT-coupled bacterial cell chip, a potent recombinant lysin against Staphylococcus strains, SA1, was identified. The SA1 was highly potent against not only S. aureus, but also both lysostaphin-resistant S. simulans and S. epidermidis cells. To this end, the SA1 may be applicable to treat both methicillin-resistant S. aureus (MRSA) and lysostaphin-resistant MRSA mutants. Biotechnol. Bioeng. 2017;114: 1648–1657.",
keywords = "bacterial cell chip, high-throughput screening, in vitro TNT, lysins, SA1",
author = "Kwon, {Seok Joon} and Domyoung Kim and Inseon Lee and Jungbae Kim and Dordick, {Jonathan S.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1002/bit.26300",
language = "English",
volume = "114",
pages = "1648--1657",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "8",

}

TY - JOUR

T1 - In vitro gene expression-coupled bacterial cell chip for screening species-specific antimicrobial enzymes

AU - Kwon, Seok Joon

AU - Kim, Domyoung

AU - Lee, Inseon

AU - Kim, Jungbae

AU - Dordick, Jonathan S.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Targeting infectious bacterial pathogens is important for reducing the evolution of antibiotic-resistant bacteria and preserving the endogenous human microbiome. Cell lytic enzymes including bacteriophage endolysins, bacterial autolysins, and other bacteriolysins are useful antibiotic alternatives due to their exceptional target selectivity, which may be used to lysins rapidly kill target bacteria and their high specificity permit the normal commensal microflora to be left undisturbed. Genetic information of numerous lysins is currently available, but the identification of their antimicrobial function and specificity has been limited because most lysins are often poorly expressed and exhibit low solubilities. Here, we report the development of bacterial cell chip for rapidly accessing the function of diverse genes that are suggestive of encoding lysins. This approach can be used to evaluate rapidly the species-specific antimicrobial activity of diverse lysins synthesized from in vitro transcription and translation (TNT) of plasmid DNA. In addition, new potent lysins can be assessed that are not expressed in hosts and display low solubility. As a result of evaluating the species-specific antimicrobial function of 11 (un)known lysins with an in vitro TNT-coupled bacterial cell chip, a potent recombinant lysin against Staphylococcus strains, SA1, was identified. The SA1 was highly potent against not only S. aureus, but also both lysostaphin-resistant S. simulans and S. epidermidis cells. To this end, the SA1 may be applicable to treat both methicillin-resistant S. aureus (MRSA) and lysostaphin-resistant MRSA mutants. Biotechnol. Bioeng. 2017;114: 1648–1657.

AB - Targeting infectious bacterial pathogens is important for reducing the evolution of antibiotic-resistant bacteria and preserving the endogenous human microbiome. Cell lytic enzymes including bacteriophage endolysins, bacterial autolysins, and other bacteriolysins are useful antibiotic alternatives due to their exceptional target selectivity, which may be used to lysins rapidly kill target bacteria and their high specificity permit the normal commensal microflora to be left undisturbed. Genetic information of numerous lysins is currently available, but the identification of their antimicrobial function and specificity has been limited because most lysins are often poorly expressed and exhibit low solubilities. Here, we report the development of bacterial cell chip for rapidly accessing the function of diverse genes that are suggestive of encoding lysins. This approach can be used to evaluate rapidly the species-specific antimicrobial activity of diverse lysins synthesized from in vitro transcription and translation (TNT) of plasmid DNA. In addition, new potent lysins can be assessed that are not expressed in hosts and display low solubility. As a result of evaluating the species-specific antimicrobial function of 11 (un)known lysins with an in vitro TNT-coupled bacterial cell chip, a potent recombinant lysin against Staphylococcus strains, SA1, was identified. The SA1 was highly potent against not only S. aureus, but also both lysostaphin-resistant S. simulans and S. epidermidis cells. To this end, the SA1 may be applicable to treat both methicillin-resistant S. aureus (MRSA) and lysostaphin-resistant MRSA mutants. Biotechnol. Bioeng. 2017;114: 1648–1657.

KW - bacterial cell chip

KW - high-throughput screening

KW - in vitro TNT

KW - lysins

KW - SA1

UR - http://www.scopus.com/inward/record.url?scp=85019874359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019874359&partnerID=8YFLogxK

U2 - 10.1002/bit.26300

DO - 10.1002/bit.26300

M3 - Article

C2 - 28369698

AN - SCOPUS:85019874359

VL - 114

SP - 1648

EP - 1657

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 8

ER -